Treatment and Referral Pathways for Epilepsy Patients in Germany: A National Database Study

This retrospective study analyzed German national health insurance records to assess epilepsy treatment pathways and guideline adherence, identifying a 0.67% national prevalence with 36% of patients classified as drug-refractory. The research validated hospital-based epilepsy center data against national databases to evaluate timely specialist escalation and optimal treatment recommendations.